Skip NavigationSkip to Content

MiR-204-5p: a novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma

  1. Author:
    Kurahashi, Ryoma
    Kadomatsu, Tsuyoshi
    Baba, Masaya
    Hara, Chiaki
    Itoh, Hitoshi
    Miyata, Keishi
    Endo, Motoyoshi
    Morinaga, Jun
    Terada, Kazutoyo
    Araki, Kimi
    Eto, Masatoshi
    Schmidt,Laura
    Kamba, Tomomi
    Linehan, W Marston
    Oike, Yuichi
  2. Author Address

    Department of Molecular Genetics., Department of Urology., Center for Metabolic Regulation of Healthy Aging (CMHA), Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan., International Research Center for Medical Sciences (IRCMS), Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto, 860-0811, Japan., Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan., Department of molecular biology, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka, 807-8555, Japan., Center for Clinical Research., Department of Nephrology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan., Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto, 860-0811, Japan., Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan., Basic Science Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD, 21702, USA., Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, CRC Rm 1-5940, Bethesda, MD, 20892, USA., Core Research for Evolutional Science and Technology (CREST), Japan, Agency for Medical Research and Development (AMED), Tokyo, Japan.,
    1. Year: 2019
    2. Date: Jun
    3. Epub Date: 2019 04 21
  1. Journal: Cancer science
    1. 110
    2. 6
    3. Pages: 1897-1908
  2. Type of Article: Article
  3. ISSN: 1347-9032
  1. Abstract:

    Xp11.2 translocation renal cell carcinoma (Xp11 tRCC) is a rare sporadic pediatric kidney cancer caused by constitutively active TFE3 fusion proteins. Tumors in patients with Xp11 tRCC tend to recur and undergo frequent metastasis, in part due to lack of methods available to detect early stage disease. Here we generated transgenic (Tg) mice overexpressing the human PRCC-TFE3 fusion gene in renal tubular epithelial cells, as an Xp11 tRCC mouse model. At 20 weeks of age, mice showed no histological abnormalities in kidney but by 40 weeks exhibited Xp11 tRCC development and related morphological and histological changes. miR-204-5p levels in urinary exosomes of 40-week-old Tg mice exhibiting tRCC were significantly elevated compared with levels in control mice. miR-204-5p expression also significantly increased in primary renal cell carcinoma cell lines established both from Tg mouse tumors and from tumor tissue from two Xp11 tRCC patients. All of these lines secreted miR-204-5p-containing exosomes. Notably, we also observed increased miR-204-5p levels in urinary exosomes in 20-week-old renal PRCC-TFE3 Tg mice prior to tRCC development, and those levels were equivalent to those in 40-week-old Tg mice, suggesting that miR-204-5p increases follow expression of constitutively active TFE3 fusion proteins in renal tubular epithelial cells prior to overt tRCC development. Finally, we confirmed that miR-204-5p expression significantly increases in non-cancerous human kidney cells after overexpression of a PRCC-TFE3 fusion gene. These findings suggest that miR-204-5p in urinary exosomes could be a useful biomarker for early diagnosis of patients with Xp11 tRCC. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

    See More

External Sources

  1. DOI: 10.1111/cas.14026
  2. PMID: 31006167
  3. PMCID: PMC6549932
  4. WOS: 000472977600008

Library Notes

  1. Fiscal Year: FY2018-2019
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel